Cell News and Research

RSS

New review outlines role of extracellular vesicles in cancer and aging

A new review was published in Volume 13 of Oncoscience on September 30, 2026, titled "Extracellular vesicles in health, aging and disease."

6 Nov 2026

Study uncovers new shortcut mechanism behind cancer cell division

Living cells are one of the few materials that can replicate themselves, and this is crucial for tissue development and recovering from injury or illness.

6 Nov 2026

$Refractory lichen planus-like lesions reveal underlying systemic T-cell lymphoma$

Refractory lichen planus-like lesions reveal underlying systemic T-cell lymphoma

A 61-year-old man had a 2-year history of painful mucosal lesions and pruritic violaceous plaques on the trunk and extremities.

6 Nov 2026

Towards a new approach to treating chronic blood disorders

A previously unrecognised weakness in the immune defenses against certain blood neoplasms could offer a promising target for future treatments.

6 Nov 2026

Developing brains may have a way to remove genetically abnormal neurons

A significant reduction in genetic abnormalities in cortical neurons occurs after birth, suggesting a selective elimination mechanism in brain development.

6 Nov 2026

New European real-world evidence supporting Pepaxti in heavily pretreated multiple myeloma to be presented at ASH 2026

Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, today announces that two abstracts highlighting real-world clinical outcomes for Pepaxti (melflufen) in relapsed, refractory multiple myeloma (RRMM) have been accepted for presentation at the 68th American Society of Hematology (ASH) Annual Meeting, taking place in New Orleans, USA, December 12–15, 2026.

6 Nov 2026

Evaxion will present new target validation data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia at ASH 2026 Meeting

Evaxion A/S (“Evaxion”), a clinical-stage TechBio company developing novel immunotherapies with its pioneering AI-Immunology™ platform, will present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia (AML), in a poster session at the American Society of Hematology (ASH) Annual Meeting and Exposition in New Orleans, Louisiana, December 12-15, 2026.

5 Nov 2026

Novel method identifies active tRNAs during cellular protein synthesis

In a new study in Nature Methods, researchers at the Centre for Genomic Regulation (CRG) in Barcelona describe a technique that looks only at the tRNAs on ribosomes busy making proteins.

5 Nov 2026

New genomic tools improve detection of rare DNA changes

WashU Medicine researchers have verified the accuracy of genetics tools to correctly identify all the rare DNA changes that make up an individual's genomic mosaic, paving the way to understanding these variants' impact on health and disease.

5 Nov 2026

New microscopy technique reveals how drugs affect living cells

How do cells respond to drugs? A new microscopy technique could provide more precise answers to this question in the future.

5 Nov 2026

Struggling with constipation? Two green kiwifruits a day may help

A narrative review of 33 publications found that consuming two fresh green kiwifruits daily for approximately four weeks can improve bowel movement frequency and gastrointestinal comfort in adults with functional constipation or constipation-predominant irritable bowel syndrome (IBS-C). Clinical studies reported broadly similar improvements with kiwifruit, psyllium, and prunes, although more research is needed to establish long-term benefits and differences between kiwifruit varieties.

5 Nov 2026

Hidden genetic differences in gut bacteria may hold clues to aging

Researchers analyzed approximately 12.8 million gut microbial genetic variants in 10,781 individuals across six cohorts, identifying 940 independent associations with 69 human health characteristics and environmental exposures. Nearly two-thirds of these associations were not accompanied by significant differences in bacterial species abundance, suggesting that microbial genetics can reveal relationships overlooked by conventional microbiome analyses, although causality remains unproven.

5 Nov 2026

CIRM grant funds new stem cell therapy to heal hearts

A new $6.9 million grant from the California Institute for Regenerative Medicine (CIRM) will support preclinical development of an investigational cell therapy for the heart created by USC Stem Cell scientists.

5 Nov 2026

NCCN expands agreement to improve cancer care in Vietnam

The National Comprehensive Cancer Network (NCCN) today announced the signing of a new agreement with the Viet Nam National Cancer Hospital (K Hospital) and The Vietnam Cancer Association (VCA), expanding a longstanding collaboration to improve cancer care through the adaptation and use of evidence-based clinical practice guidelines.

5 Nov 2026

AI-designed vaccine provides complete protection against diverse bird flu variants

A University of Cambridge team has had a third success with their AI-guided technique for designing vaccines against highly infectious viruses that threaten animal and human health.

5 Nov 2026

ASH establishes new blood reference ranges for Duffy-null individuals

ASH has developed new reference ranges for children and adults with Duffy-null status, a common genetic trait associated with naturally lower circulating white blood cell counts that affects more than 66% of people with African or Mediterranean ancestry in the US.

5 Nov 2026

Vulnerable DNA sites make cancer cells sensitive to PARP inhibitors

A small subset of vulnerable DNA sites can make cancer cells highly sensitive to targeted drugs called PARP inhibitors, a new study shows.

5 Nov 2026

Anti-PEG antibodies drive contrasting liposome skin toxicity across species

This new article publication from Acta Pharmaceutica Sinica B discusses how anti-polyethylene glycol antibodies affect the movement of stealth liposomes from blood into skin, revealing contrasting distribution and toxicity patterns in mice and rats.

5 Nov 2026

New covalent inhibitor targets DNAJC9 to reduce sepsis inflammation

This new article publication from Acta Pharmaceutica Sinica B discusses the discovery of the covalent inhibitor A12 and the identification of DNAJC9 as a potential drug target for sepsis-associated inflammation.

5 Nov 2026

Rising colorectal cancer rates prompt earlier routine screening recommendations

Forty-five is the new 60 – at least when it comes to colonoscopies. That may not be the party you look forward to, but it could save your life. According to the Cancer Research Institute, 1 in 5 colorectal cancers are diagnosed in patients under age 55, making what was once thought of as an older person's disease one of the fastest-growing cancers in young people.

5 Nov 2026